Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1994-05-05
1998-11-24
Ulm, John
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530325, 530376, 530350, C07K 14705
Patent
active
058408363
ABSTRACT:
Pancreatic islet cell antigens (ICA) that bind with antibodies found in the sera of patients afflicted with insulin-dependent (Type I) diabetes mellitus (IDDM). ICA proteins are expressed by recombinant cloning vehicles comprising DNA inserts isolated from islet cells. Full sequence native ICA proteins, or protein or peptide fragments thereof, can be used in the diagnosis of IDDM and in detecting or blocking human immunoglobulin, T-cells, or B-cells involved in IDDM.
REFERENCES:
patent: 5200318 (1993-04-01), Rabin et al.
Srikanta et al. (1986) Mol. Biol. Med 3:113-127.
Karounos et al. (1988) Diabetes 37(5) :30A.
Moncayo et al. (1988) Diabetologia 31(7) :523A.
Glover (1984) "Principles of Cloning DNA" Gene Cloning pp. 1-19.
Bayer Corporation
Ulm John
LandOfFree
Pancreatic islet cell antigens obtained by molecular cloning does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pancreatic islet cell antigens obtained by molecular cloning, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pancreatic islet cell antigens obtained by molecular cloning will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1703273